NCT02484248View on ClinicalTrials.gov

Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia

PHASE3RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

April 1, 2027

Study Completion Date

April 1, 2027

Conditions
Functional Dyspepsia
Interventions
DRUG

Ketotifen

Ketotifen is an anti-histamine approved by the U.S. FDA to prevent and treat itching of the eyes caused by allergies.

DRUG

Placebo

The placebo tablet looks identical to the ketotifen tablet, but does not contain ketotifen.

Trial Locations (1)

64108

RECRUITING

The Children's Mercy Hospital, Kansas City

All Listed Sponsors
lead

Children's Mercy Hospital Kansas City

OTHER